WiTH safer premedication for thyroidectomy, thyrotoxic crisis is now seldom seen postoperatively. It still occurs, however, when infections or surgical operations complicate uncontrolled thyrotoxicosis, and it is a rare complication of thyrotoxicosis during pregnancy and especially after delivery. We report here a patient who developed a severe thyrotoxic crisis in the ninth month of pregnancy, and whose illness was complicated 'by transient myasthenia gravis. So far as we can determine, there is no previous record of myasthenia occurring in a 'thyrotoxic crisis.
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Case Report
The patient, a married woman aged 20 years, was seen early in her first pregnancy by her general practitioner on September 17th, 1963, complaining of nausea, vomiting and dizziness for -which triflucperazine was prescribed. A tachycardia was noted then, and her doctor "wondered if she was thyrotoxic". No further action was taken and her pregnancy seemed to make good progress thereafter, although she had gained only 6.4 kg. (14 lb.) by the thirty-sixith week.
She was admitted to Withington Hospital as an emergency on March 24th, 1964 . During the previous eight days, she had ;had severe 'bilateral throbbing frontal headaches, tiredness and a dry cough. Three days before admission, she developed profuse sweating and rigors; the headaches and fatigue 'became worse, she vomited twice and felt very ill. On the evening of admission, her temperature had risen to 106°F. and her pulse rate to 1,80/min.
On examination at the hospital, she was thin, flushed, apathetic, sweating and very ill; the hands were warm and the temperature was 103.4'F. There was a marked stare and von Graefe's sign was positive; there was no tremor. The thyroid gland was just palpable, and there was a thrill and a loud continuous murmur over it. The pulse rate was 144/min., iB.P. 95/45 mm. Hg., and J.V.P. raised 10 cm. above the sternal angle; no oedema. The heart was hyperdynamic; there was a loud gallop rhythm and a basal ejiection systolic murmur conducted to the neck. Examination of the chest was normal. The abdomen contained a gravid uterus consistent with a thirty-six weeks' pregnancy. The tendon reflexes were hyperactive.
Investigations. Hib 8.6 g./100 ml.; WBC 6,500/ cu. mm., normal differential count. The blood urea, serum sodium, chloride and bicarbonate niormal; serum 'potassium 2.95 mEq/1. Chest X-ray normal.
ECG: sinus tachycardia. Lumbar puncture: normal CSF normal 'pressure. A twenty-four-hour specimen of urine contained 250 ,g. of catecholamines. The serological tests for autoimmune thyroiditis were negative. Unfortunately, treatment with iodide was begun 'before a specimen of blood for estimation of protein-bound iodine was obtained.
On dhart) , and ten 'hours later her temperature was 95.6'F., and the pulse rate 104 per minute. After *twen,ty4four hours, s-odium iodide was withdrawn for six hours but her condition immediately relapsed; after a further six hours the temperature was 104.2'F., and the pulse rate 180 per minute. The original dosage of sodium iodide was restored and she again responded; by mid-day on March 25th, the temperature was normal and the pulse rate 100 per minute. This treatment was continued and after her condition had remained satisfactory for 24 hours a further attempt was made to reduce the dosage of sodium iodide because of the theoretical risk oif acute iodism. At the same time, guanethidine was added in an attempt to suppress -the manifestations of thyrotoxicosis. A further deterioration with weakness, cough, fever and tachycardia again ensued within a few hours of reducing the dosage of sodium iodide and her condi,tion rapidly 'became alarming. She became semicomatose and a left sixth nerve palsy developed. Within four 'hours, she developed ptosis, divergent squint, impairment of upward gaze of the eyes, a bilateral lower motor neurone facial palsy, dysphagia, dysarthria and a "myasthenic snarl". 10 mg. of edrophonium chloride (Tensilon) was given intraven-ously and caused a dramatic temporary remission of the myasthenia.
Large doses of sodium iodide were re-introduced intravenously, steroids were gradually withdrawn for fear of exacerbating the myasthenia, neostigmine was given 'by mouth, and a course of chloramphenicol was given in case an underlying infection was responsible 'for precipitating and perpetuating the thyrotoxic crisis. The latter again came under control within a few hours, but after 24 hours the myasthenia was unchanged. Neostigmine was then added to the intravenous infusion in a dosage of 7.5 mg. (later 9 mg.) six-hourly; after a further 24 hours there was slow improvement in the neurological signs. Her general condition then began to improve and after two days the thyrotoxicosis was under control and the myasthenia ihad ibeen completely suppressed. On March 30th, an alarming episode occurred. Whilst talking to a nurse, the patient suddenly lost consciousness and had a generalised tonic convulsion. This was thought to be due to overdosage of neostig- (Weaver, Jones and Smith, 1956) .
Myasthenia gravis and thyrotoxicosis are known to co-exist more commonly than would be expected by chance, but the nature of the association is very obscure. Sometimes a "seesaw" effect has been described, the myasthenia appearing as the thyrotoxicosis comes under control (Robbins and Burkle, 1960; Monro, 1963) . Weickhardt and Redmond (1960) throw doubt on this and point out that sometimes myasthenia may appear when the patient is severely thyrotoxic, as in our own case. It is clear from published cases only that there is no constant pattern. One factor which may have operated in our own patient is that the myasthenia followed large doses of chlorpromazine, which is thought sometimes to precipitate weakness in a myasthenic patient. (McQuillan, Gross and Johns, 1963) .
Our patient was given so many different agents during the height of her illness that it may be thought difficult to identify those that were therapeutically most useful. The management of thyrotoxic crisis in recent years has been improved by the introduction of chlorpromazine, and possibly also by corticosteroids, guanethidine and reserpine; the latter two drugs are useful in suppressing the peripheral manifestations of thyrotoxicosis whilst not curing the disease.
Corticosteroids are advised because of the possibility of adrenocortical exhaustion in thyrotoxic crisis. In spite of the use of all these drugs, however, it was our distinct impression that intravenous sodium iodide was by far the most effective agent in the management of our patient. We repeatedly o,bserved that increasing the concentration of iodide in the infusion quickly led to reduction in fever and tachycardia, whilst both relapsed whenever iodide was discontinued. A daily dose of 4 g. of iodide was tolerated without evidence of ill effect (see chart).
It is therefore suggested that in the management of thyrotoxic crisis, intravenous sodium iodide should be given in a dosage of at least 0.5 g. six-hourly. Reductions in the dose should be made cautiously, and the dose increased if fever and tachycardia return or are uncontrolled. The patient should be nursed in an oxygen tent; skilled nursing care and observation are essential.
Hyperpyrexia and restlessness should be controlled by chlorpromazine, tepid sponging and phenobarbitone. Intravenous hydrocortisone should also be given. Guanethidine and reserpine may be used for their symptomatic value. A careful search must be made for any precipitating infection, and appropriate treatment instituted. Heart failure must be controlled by digoxin; the value of propranolol in severe thyrotoxicosis is currently being assessed. Carbimazole should be started immediately, but will not have much therapeutic effect for two weeks. Summary A woman who developed a thyrotoxic crisis in the ninth month of pregnancy is described. At the height of her illness, she developed neostigmine-responsive myasthenia lasting four days.
The management of thyrotoxic crisis is discussed: although chlorpromazine, phenobarbitone, corticosteroids, guanethidine and reserpine probably played a useful part, it is emphasised that the use of these drugs does not render superfluous the use of intravenous iodide; in our patient this appeared to be the most effective agent.
IT HAS been estimated (Annotation, 1962) (Leonard, 1953; Kersley and Mandell, 1963; Kaplin, 1955; Venning, 1957; Hale and DeGruchy, 1960; Rankin, 1961; Lander and Bonnin, 1962; McCarthy and Chalmers, 1964; Humble, 1964; Woodliff and Dougan, 1964) . Our seardh of the literature has revealed 15 cases of aplastic anaemia in patients taking phenylibutazone; in 7 of these cases the marrow failure proved fatal.
We record the following case of fatal aplastic anaemia because it re-emphasilses the possible dangers of this drug and the need for extreme wariness when it is being used.
A 79-year-old widow was admitted to hospital on the 6th of November, 1964. Pernicious anaemia had been diagnosed in 1954 and had been well controlled with cytamen given every three weeks. About the end of 1963 she had complained of "arthritic pains" in the hands and legs, and her own doctor prescribed phenylbutazone, 100 mg. tablets, one thrice daily. In fact she took the tablets rather erratically, so that the total amount taken over a period of Sternal Marrow: Sections of the marrow showed 95% fat with only an occasional island of haemopoietic tissue (Fig. la & b) . These islands were mainly lymphocytes and showed no polymorphonuclear cells or megakaryocytes. Differential count showed a leuco-erythroid ratio of 5 to 1. The leucopoietic tissue was 75% lymphocytes with a few lymphoblasts. Primitive cells were not frequent. Erythropoesis was normoblastic with no arrest of maturation. The overall picture was that of aplasia, affecting most severely thrombocytes and granulocytes; to a slightly less degree the erythrocytes.
